Literature DB >> 8039159

Cytogenetic and molecular cytogenetic analysis of sacral chordoma.

J A Bridge1, D Pickering, J R Neff.   

Abstract

A specific or characteristic anomaly has not yet been identified in chordoma. Cytogenetic analysis of a sacral chordoma from a 70-year-old male revealed the following chromosomal complement: 42,XY,add(1)(p11), -3,der(4)t(4;?;?18;?)(q12;?;?;), -6, -9, -14,der(16) t(4;?;16)(q12;?;q11), der(17)add(17)(p12) t(17;18)(q11;p11),der(18)del(18)(p11)add(18)(q?)[6]/42, idem,der(9)t(6;9)(q11;p11)[4]/46,XY[10]. In situ hybridization with chromosome-specific paint probes assisted in identifying several of the rearrangements formerly designated as marker chromosomes. Although some of the anomalies observed appear unique to this case, others are similar to those previously reported in chordoma.

Entities:  

Mesh:

Year:  1994        PMID: 8039159     DOI: 10.1016/0165-4608(94)90210-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.

Authors:  D Gottschalk; M Fehn; S Patt; W Saeger; T Kirchner; T Aigner
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

2.  Clonality studies in sacral chordoma.

Authors:  Lance Klingler; Rita Trammell; D Gordon Allan; Merlin G Butler; Herbert S Schwartz
Journal:  Cancer Genet Cytogenet       Date:  2006-11

3.  Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literature.

Authors:  Kristopher T Kimmell; Hayan Dayoub; Ethan D Stolzenberg; Eric H Sincoff
Journal:  Surg Neurol Int       Date:  2010-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.